TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman

Core Viewpoint - A class-action lawsuit has been filed against TransMedics Group, Inc. alleging fraudulent practices and safety issues, impacting investors who acquired securities between February 28, 2023, and January 10, 2025 [1][2]. Group 1: Allegations and Claims - The lawsuit claims that TransMedics made false and misleading statements, failed to disclose crucial information, and engaged in kickbacks, fraudulent overbilling, and coercive tactics to enhance business and revenue [2][5]. - It is alleged that the company concealed safety problems and lacked adequate safety oversight, which exposed it to increased regulatory risk [2][5]. Group 2: Events Impacting Stock Price - On February 21, 2024, Representative Paul Gosar accused TransMedics of misappropriating corporate resources, leading to a stock price drop following media coverage [3]. - A report released by activist short seller Scorpion Capital on January 10, 2025, accused TransMedics of overbilling hospitals and coercing customers, further depressing the company's stock price [4]. Group 3: Investigation and Legal Proceedings - Hagens Berman is investigating the claims against TransMedics and is urging investors who suffered losses to come forward [2][5]. - The lead plaintiff deadline for the class-action lawsuit is set for April 15, 2025 [2].